Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 43/54
John
Breaux
U.S. Senate · D-LA
Taken from pharma & insurers
$14,099
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 43/54
Pharma & Health$14,099
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 43 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$14,099
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Then, after office
Joined a hedge-fund trade group's board and counted PhRMA among his lobbying clients.
Source: Business Wire; Center for Public Integrity
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
Don't recognize a logo? Here's the key.
Pharma & Health$14,099
Johnson & Johnson$12,600
Amgen$1,000
Merck$499